Intrauterine Baclofen Exposure: A Multidisciplinary Approach

Maternal use of the antispasmodic baclofen during pregnancy is an uncommon clinical scenario and leads to uncertainty regarding neonatal risks. We present a team-based, peripartum management plan designed for safe monitoring and minimizing the risk of neonatal withdrawal after unusual drug exposure....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2004-08, Vol.114 (2), p.e267-e269
Hauptverfasser:	Moran, Lisa R, Almeida, Pamela G, Worden, Susan, Huttner, Kenneth M
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics, Opioid - adverse effects Analgesics, Opioid - therapeutic use Baclofen - adverse effects Baclofen - therapeutic use Breast Feeding Female GABA Agonists - adverse effects GABA Agonists - therapeutic use Humans Infant, Newborn Muscle Relaxants, Central - adverse effects Muscle Relaxants, Central - therapeutic use Oxycodone - adverse effects Oxycodone - therapeutic use Pregnancy Pregnancy Complications - drug therapy Reflex Sympathetic Dystrophy - drug therapy Substance Withdrawal Syndrome - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Maternal use of the antispasmodic baclofen during pregnancy is an uncommon clinical scenario and leads to uncertainty regarding neonatal risks. We present a team-based, peripartum management plan designed for safe monitoring and minimizing the risk of neonatal withdrawal after unusual drug exposure. Incorporating the expertise of neonatology, nursing, pharmacy, neurology, and the lactation service, as well as parental input, this consensus approach was implemented in a case of maternal oral baclofen use with a successful outcome for the infant and family.
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.114.2.e267